LGND vs REGN: Which Stock is Better?

Side-by-side comparison of Ligand Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

LGND

Ligand Pharmaceuticals Inc

$231.82

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricLGNDREGNWinner
Market Cap$4.62B$79.35BREGN
P/E Ratio37.8218.08REGN
EPS (TTM)$6.13$41.51REGN
Revenue Growth0.4%0.0%LGND
Gross Margin64.3%44.6%LGND

Analyze LGND

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LGND or REGN a better investment?

Comparing LGND and REGN: Ligand Pharmaceuticals Inc has a market cap of $4.62B while Regeneron Pharmaceuticals Inc has $79.35B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LGND and REGN?

LGND (Ligand Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LGND or REGN?

Based on P/E ratios, REGN trades at a lower multiple (18.1x vs 37.8x).

Which is growing faster: LGND or REGN?

LGND has higher revenue growth at 0.4% vs 0.0% for REGN.

Which company is more profitable: LGND or REGN?

Ligand Pharmaceuticals Inc (LGND) has higher gross margins at 64.3% compared to 44.6% for REGN.

Which is the larger company: LGND or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.35B compared to $4.62B for LGND.

Should I buy LGND or REGN in 2026?

Both LGND and REGN have investment merit. LGND trades at $231.82 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LGND and REGN stock?

Key differences: Market Cap ($4.62B vs $79.35B), P/E Ratio (37.8x vs 18.1x), Revenue Growth (0.4% vs 0.0%), Gross Margin (64.3% vs 44.6%).

Popular Stock Comparisons